Theingi Win is a Cardiology physician affiliated with University of California, Los Angeles. OpenAlex indexes 31 publications with 325 citations (h-index 8).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1700 Mount Vernon Ave
Bakersfield, CA 933064018
Telephone
661-326-2000Registry record last updated 8 Oct 2018.
Industry payments
10 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Edwards Lifesciences CorporationProgram year20251 payment
- ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)Program year20241 payment
- ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)Program year20233 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
80.2%Beta blocker21%Metoprolol Succinate62%Carvedilol21%Metoprolol Tartrate11%Sotalol Af6%Part D<11 patientsStatin18.2%Rosuvastatin Calcium60%Atorvastatin Calcium40%Part D≥54 patients+ 11 more classes in this area
Metabolism & gastrointestinal
10.9%SGLT2 inhibitor7%Jardiance73%Farxiga27%Part D<11 patientsPotassium supplement2.6%Potassium Chloride100%Part D≥15 patients+ 1 more class in this area
Blood & clotting
8.9%Factor Xa inhibitor6.4%Eliquis82%Xarelto18%Part D<11 patientsP2Y12 inhibitor2.5%Clopidogrel100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- TO CLOSE OR NOT TO CLOSE: A CASE OF PATENT FORAMEN OVALE IN A SICKLE CELL DISEASE PATIENT PRESENTING WITH STROKE
Journal of the American College of Cardiology
2023 - Acute Pericarditis Leading to a Diagnosis of SLE: A Case Series of 3 Patients
Journal of Investigative Medicine High Impact Case Reports
2022 - Clonidine Overdose as an Unusual Cause of Heart Failure
Journal of Investigative Medicine High Impact Case Reports
2022 - UNIQUE PRESENTATION OF CLONIDINE OVERDOSE CAUSING VASOSPASM AND HEART FAILURE
Journal of the American College of Cardiology
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Dennis Slamon, MD
University of California, Los Angeles
Beth Karlan, MD
University of California, Los Angeles
Richard Casaburi, MD
University of California, Los Angeles
Robert Modlin, MD
University of California, Los Angeles
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”